Ophthalmological Microscopes
Welcome to Ophthalmological Microscopes.Detection of Bronchial Neoplasia in Uranium Miners by Autofluorescence Endoscopy (SAFE-1000)
Detection of Bronchial Neoplasia in Uranium Miners by Autofluorescence Endoscopy (SAFE-1000)
Click Here to read the entire article...
Other Articles:
| • | EpiDerm's Skin Irritation Test Fully Validated In European Union |
| MatTek Corporation announced that the ECVAM Scientific Advisory Committee (ESAC) endorsed the scientific validity of the Modified EpiDerm Skin Irritation Test (SIT) at its November meeting. ESAC concluded that the Modified EpiDerm SIT has sufficient accuracy and reliability for the prediction of skin irritating and non-irritating test substances. The Updated EpiDerm SIT is a modification of the previously validated EpiDerm skin irritation method (ESAC Statement, April 2007). | |
| Click Here to read the entire article... |
|
| • | Intelerad Ranks Number One in the KLAS Ambulatory PACS Report for the Second Consecutive Year |
| Intelerad Medical Systems, an industry leading PACS supplier to imaging centers, teleradiology groups and hospitals, is pleased to announce that Intelerad has been ranked first overall in the 2008 Ambulatory PACS Report by KLAS Enterprises, LLC. A total of 17 vendors qualified for inclusion in this year’s PACS Ambulatory Report. KLAS conducted over 550 in-depth interviews to produce an overall score for each of the 17 vendors. Intelerad was ranked first by KLAS with a total score of 91.9 out of 100, three points above the nearest competitor and a full nine points above the market segment ave... | |
| Click Here to read the entire article... |
|
| • | Innovation is the Key to Cirque Du Soleil's Success, says Prof. Quintanilla |
![]() The long-lasting success of the entertainment company Cirque Du Soleil stems from its ability continually innovate, said IESE Prof. Javier Quintanilla, during a Continuing Education session. |
|
| Click Here to read the entire article... |
|
| • | |
| Click Here to read the entire article... |
|
| • | [Anatomy and Pathology] The Normal Human Choroid Is Endowed with a Significant Number of Lymphatic Vessel Endothelial Hyaluronate Receptor 1 (LYVE-1)-Positive Macrophages |
|
LYVE-1 immunohistochemistry in the human choroid shows numerous LYVE-1 positive macrophages but reveals absence of lymphatic vessels. |
|
| Click Here to read the entire article... |
|
| • | [Knee] Unicompartmental or total knee replacement: THE 15-YEAR RESULTS OF A PROSPECTIVE RANDOMISED CONTROLLED TRIAL |
|
Between 1989 and 1992 we had 102 knees suitable for unicompartmental knee replacement (UKR). They were randomised to receive either a St Georg Sled UKR or a Kinematic modular total knee replacement (TKR). The early results demonstrated that the UKR group had less complications and more rapid rehabilitation than the TKR group. At five years there were an equal number of failures in the two groups but the UKR group had more excellent results and a greater range of movement. The cases were reviewed by a research nurse at 8, 10 and 12 years after operation. We report the outcome at 15 years follow-up. A total of 43 patients (45 knees) died with their prosthetic knees intact. Throughout the review period the Bristol knee scores of the UKR group have been better and at 15 years 15 (71.4%) of the surviving UKRs and 10 (52.6%) of the surviving TKRs had achieved an excellent score. The 15 years survivorship rate based on revision or failure for any reason was 24 (89.8%) for UKR and 19 (78.7%) for TKR. During the 15 years of the review four UKRs and six TKRs failed. The better early results with UKR are maintained at 15 years with no greater failure rate. The median Bristol knee score of the UKR group was 91.1 at five years and 92 at 15 years, suggesting little functional deterioration in either the prosthesis or the remainder of the joint. These results justify the increased use of UKR. |
|
| Click Here to read the entire article... |
|
By editors@medicalnewstoday.com (MNT Editors) - © 2008, Hindawi Publishing Corporation. All rights reserved. - version: v1.5 build A
